Otros idiomas NewGLAB Pharma CO.,LTD

Acciones

A214870

KR7214870008

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 09/03/2023			Varia. Cinco días.	Varia. 1 de enero.
1.383 ^KRW	-27,44 %		-.--%	-.--%

2023

NewGLAB Pharma CO.,LTD presenta los resultados del primer trimestre finalizado el 31 de marzo de 2023

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	04/03
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors	22/02
NewGLAB Pharma CO.,LTD(KOSDAQ:A214870) dropped from S&P Global BMI Index	19/06/23
NewGLAB Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	05/04/22
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	30/11/21
NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding	22/03/21
NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding	12/03/21
NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	20/10/20
NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	28/09/20
NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding	08/11/19
NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding	16/10/19
NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index	23/09/19
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	19/07/19
An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International.	04/06/19
NewGLAB CO.,LTD announced that it has received KRW 10.000001088 billion in funding	29/04/19
NewGLAB CO.,LTD announced that it has received KRW 5 billion in funding	12/04/19
HDPRO Co., Ltd. announced that it expects to receive KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm	19/12/18
Arenel International Co., Ltd. acquired 13.1% stake in HDPRO Co., Ltd. from NextEye Co., Ltd. for KRW 11 billion.	19/12/18
HDPRO Co., Ltd. announced that it expects to receive KRW 10.000001088 billion in funding	13/07/18

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas NewGLAB Pharma CO.,LTD

Acciones

A214870

KR7214870008

Otros idiomas

Filtros